Related Articles
bZIP transmembrane transcription factor CREBH: Potential role in non‑alcoholic fatty liver disease (Review)
The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease
Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)
miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1
Potential intervention target of atherosclerosis: Ferroptosis (Review)